Paradoxically, amplification of DEPTOR has been shown to correlate with worse progression-free survival [144], while a reduction in DEPTOR protein and mRNA transcript levels has also been implicated with prostate cancer progression [220]. The gene discussed is DEPTOR; the disease is prostate carcinoma.